These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 8530829)

  • 21. Cyclosporine A inhibits protein-kinase-C-mediated amylase release from isolated rat pancreatic acini.
    Höcker M; Waschulewski IH; Kern HF; Domagk KA; Schwarzhoff R; Fölsch UR; Schmidt WE
    Digestion; 1994; 55(6):380-8. PubMed ID: 7535711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different effects of trypsin inhibitors on intestinal gene expression of secretin and on pancreatic bicarbonate secretion in CCK-A-receptor-deficient rats.
    Kawanami T; Suzuki S; Yoshida Y; Kanai S; Takata Y; Shimazoe T; Watanabe S; Funakoshi A; Miyasaka K
    Jpn J Pharmacol; 1999 Dec; 81(4):339-45. PubMed ID: 10669038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of an inhibitor of myosin light chain kinase on amylase secretion from rat pancreatic acini.
    Mizuno N; Naruse S; Kitagawa M; Ishiguro H; Hayakawa T
    Biochem Biophys Res Commun; 2000 Mar; 269(3):792-7. PubMed ID: 10720494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats.
    Miyasaka K; Nakamura R; Kitani K
    J Gerontol; 1989 Jul; 44(4):M136-40. PubMed ID: 2738309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
    Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
    Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased pancreatic CCK receptor binding and CCK-stimulated amylase release in Zucker obese rats.
    McLaughlin CL; Peikin SR; Baile CA
    Physiol Behav; 1984 Jun; 32(6):961-5. PubMed ID: 6208569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and functional changes of exocrine pancreas induced by FK506 in rats.
    Doi R; Inoue K; Chowdhury P; Kaji H; Rayford PL
    Gastroenterology; 1993 Apr; 104(4):1153-64. PubMed ID: 7681795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical characterization of the effects of FK506 on signal transduction in exocytotic function of rat pancreatic acini.
    Doi R; Inoue K; Chowdhury P; Rayford PL
    J Pharmacol Exp Ther; 1993 Feb; 264(2):873-8. PubMed ID: 7679738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of AA861, a 5-lipoxygenase inhibitor, on amylase secretion from rat pancreatic acini.
    Sato S; Adachi H; Noguchi M; Honda T; Onishi S; Aoki E; Torizuka K
    Biochim Biophys Acta; 1988 Jan; 968(1):1-8. PubMed ID: 2447953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of cholecystokinin and vasoactive intestinal polypeptide on function of mouse pancreatic acini in vitro.
    Burnham DB; McChesney DJ; Thurston KC; Williams JA
    J Physiol; 1984 Apr; 349():475-82. PubMed ID: 6204039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of camostate administration for two weeks on experimental pancreatitis in mice and rats.
    Leonhardt U; Seidensticker F; Stöckmann F; Creutzfeldt W
    Pancreas; 1993 Jan; 8(1):98-102. PubMed ID: 7678329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amylase secretion by isolated pancreatic acini after chronic cholecystokinin treatment in vivo.
    Otsuki M; Williams JA
    Am J Physiol; 1983 Jun; 244(6):G683-8. PubMed ID: 6190411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supramaximal CCK and CCh concentrations abolish VIP potentiation by inhibiting adenylyl cyclase activity.
    Akiyama T; Hirohata Y; Okabayashi Y; Imoto I; Otsuki M
    Am J Physiol; 1998 Nov; 275(5):G1202-8. PubMed ID: 9815052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of synthetic protease inhibitor camostate on pancreatic exocrine function in rats.
    Otsuki M; Ohki A; Okabayashi Y; Suehiro I; Baba S
    Pancreas; 1987; 2(2):164-9. PubMed ID: 3628222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High concentrations of cholecystokinin octapeptide suppress protein kinase C activity in guinea pig pancreatic acini.
    Kimura T; Honda T; Higashi T; Konishi J
    Peptides; 1996; 17(6):917-25. PubMed ID: 8899809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of sensitivity to cholecystokinin stimulation of isolated pancreatic acini from genetically diabetic rats.
    Otsuki M; Akiyama T; Shirohara H; Nakano S; Furumi K; Tachibana I
    Am J Physiol; 1995 Mar; 268(3 Pt 1):E531-6. PubMed ID: 7534992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postreceptor modulation of action of VIP and secretin on pancreatic enzyme secretion by secretagogues that mobilize cellular calcium.
    Collen MJ; Sutliff VE; Pan GZ; Gardner JD
    Am J Physiol; 1982 Apr; 242(4):G423-8. PubMed ID: 6175231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbachol acts through protein kinase C to modulate cholecystokinin receptors on pancreatic acini.
    Louie DS; Chung OY
    Am J Physiol; 1991 Dec; 261(6 Pt 1):G981-6. PubMed ID: 1722647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effect of single and repeated administrations of a protease inhibitor (Camostate) on pancreatic secretion in man.
    Adler G; Müllenhoff A; Bozkurt T; Göke B; Koop I; Arnold R
    Scand J Gastroenterol; 1988 Mar; 23(2):158-62. PubMed ID: 3363288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscarinic cholinergic induced secretin subsensitivity in rat isolated pancreatic acini. Effects on amylase release, cyclic adenosine monophosphate and inositol phosphate formation.
    Larose L; Leclerc L; Asselin J; Ruel S; Morisset J
    Pancreas; 1989; 4(1):71-8. PubMed ID: 2470085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.